WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia: Moderna begins first human trial of Bundibugyo Ebola vaccine — Warptech Lab News

Storia in 10 fonti

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna starts human trials for Bundibugyo Ebola vaccine, aiming to provide 500,000 doses to low-income countries if approved.

Raccontata da

morningstar.com

nationalpost.com

it.euronews.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

thehindu.comStai leggendo2 g fa

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna starts human trials for Bundibugyo Ebola vaccine, aiming to provide 500,000 doses to low-income countries if approved.

Timeline cronologica

martedì 4 agosto 2026·morningstar.com
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of…
martedì 4 agosto 2026·thestar.com
Health Canada authorizes Moderna clinical trial for new Ebola vaccine candidate
TORONTO - Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of Ebola blamed for the largest outbreak ever reported

2 g fa

Moderna starts human trials for Ebola vaccine amid Congo outbreak

Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo continues to battle its fastest-growing outbreak on record.

Leggi questa versione → originale

abcnews.com3 g fa

Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak

Moderna said on Tuesday it has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is currently circulating in the eastern DRC.

Leggi questa versione → originale

morningstar.com3 g fa

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine…

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of our expanded collaboration with the…

Leggi questa versione → originale

cbc.ca3 g fa

Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo | CBC News

Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the Ebola virus, which continues to surge throughout the Democratic Republic of the Congo.

Leggi questa versione → originale

iol.co.za2 g fa

Canada authorizes clinical trials of Moderna Ebola vaccine

The Phase 1 trial of the mRNA vaccine will assess the candidate vaccine's safety, determine the right dosage range and identify any side effects.

Leggi questa versione → originale

martedì 4 agosto 2026·

cbc.ca

Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo | CBC News

Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the Ebola virus, which continues to surge throughout the…

martedì 4 agosto 2026·

abcnews.com

Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak

Moderna said on Tuesday it has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is currently circulating in the eastern DRC.

mercoledì 5 agosto 2026·

thehindu.com

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna starts human trials for Bundibugyo Ebola vaccine, aiming to provide 500,000 doses to low-income countries if approved.

mercoledì 5 agosto 2026·

iol.co.za

Canada authorizes clinical trials of Moderna Ebola vaccine

The Phase 1 trial of the mRNA vaccine will assess the candidate vaccine's safety, determine the right dosage range and identify any side effects.

mercoledì 5 agosto 2026·

benzinga.com

Why Is Moderna Stock Gaining Wednesday? - Moderna (NASDAQ:MRNA)

Moderna starts Phase 1 trials for Ebola vaccine mRNA-1469. See premarket MRNA stock reaction, analyst updates, and ETF exposure.

mercoledì 5 agosto 2026·

nationalpost.com

Moderna authorized to launch its Ebola vaccine clinical trials in Canada

Canada's ministry of health has granted Moderna authorization to begin clinical trials on a vaccine against the Bundibugyo strain of Ebola.

mercoledì 5 agosto 2026·

euronews.com

Moderna starts human trials for Ebola vaccine amid Congo outbreak

Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo continues to battle its fastest-growing outbreak on…

mercoledì 5 agosto 2026·

it.euronews.com

Moderna avvia i test sul vaccino Ebola Bundibugyo mentre l'epidemia in Congo continua

Moderna ha vaccinato i primi partecipanti a una sperimentazione sul vaccino contro il ceppo Bundibugyo dell’Ebola, mentre la RDCongo affronta il suo focolaio in crescita più…

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com